Looking Beyond the Skin in Psoriasis Treatment Selection
Dr. Adam Friedman discusses the importance of screening psoriasis patients for comorbidities like psoriatic arthritis and gastrointestinal issues. He emphasizes that effective treatment requires looking beyond skin symptoms to address systemic health concerns.
Why it matters
Early detection of comorbidities in psoriasis patients can significantly improve long-term health outcomes and prevent permanent joint damage.
In this Expert Perspectives video, Adam Friedman, MD, discusses screening for psoriatic arthritis and other comorbidities, the potential impact of earlier systemic treatment, and considerations when selecting oral therapies for psoriasis.
Psoriasis extends beyond the skin, making recognition of associated joint disease and other comorbidities an important part of treatment selection. In this Dermatology Times Expert Perspectives video, Adam Friedman, MD, professor and chair of dermatology at the George Washington University School of Medicine and Health Sciences in Washington, DC, discusses practical strategies for identifying comorbid disease and individualizing systemic therapy.
Screening Beyond the Skin
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in